KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $3.7 million.

  • Co-Diagnostics' Total Current Liabilities fell 3631.01% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 3631.01%. This contributed to the annual value of $7.3 million for FY2024, which is 2728.37% up from last year.
  • Latest data reveals that Co-Diagnostics reported Total Current Liabilities of $3.7 million as of Q3 2025, which was down 3631.01% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Total Current Liabilities ranged from a high of $13.0 million in Q1 2022 and a low of $3.6 million during Q1 2023
  • Its 5-year average for Total Current Liabilities is $5.9 million, with a median of $5.3 million in 2024.
  • Per our database at Business Quant, Co-Diagnostics' Total Current Liabilities soared by 26088.44% in 2021 and then plummeted by 7227.44% in 2023.
  • Quarter analysis of 5 years shows Co-Diagnostics' Total Current Liabilities stood at $12.6 million in 2021, then tumbled by 69.25% to $3.9 million in 2022, then soared by 48.38% to $5.7 million in 2023, then increased by 27.28% to $7.3 million in 2024, then plummeted by 49.52% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $3.7 million for Q2 2025, and $5.4 million during Q1 2025.